Benzimidazole-Pyrimidine Hybrids: Synthesis and Medicinal Properties

Area of Science:

• Medicinal Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Heterocyclic compounds, specifically benzimidazoles and pyrimidines, are vital in medicinal chemistry.
• Hybrid heterocyclic compounds often exhibit enhanced therapeutic properties compared to single-ring structures.
• Recent research focuses on combining benzimidazole and pyrimidine scaffolds to develop novel therapeutic agents.

Purpose of the Study:

• To review the synthesis methods and medicinal properties of benzimidazole-pyrimidine hybrids.
• To summarize structure-activity relationship (SAR) studies for these hybrids over the past 20 years.
• To highlight the potential of these hybrids as therapeutic agents for various diseases.

Main Methods:

• Comprehensive literature search using keywords such as "benzimidazole", "pyrimidine", "Biginelli", and "benzimidazole-pyrimidine hybrids".
• Inclusion of peer-reviewed scientific articles focusing on anticancer, antiviral, antimicrobial, and anti-inflammatory activities.
• Analysis of reported IC50 and MIC values to assess compound potency.

Main Results:

• Benzimidazole-pyrimidine hybrids demonstrate significant anticancer activity with IC50 values in the nanomolar range.
• These hybrids exhibit potent antimicrobial properties against a wide spectrum of infections (MIC values in µM to nM range).
• Antiviral efficacy was observed against SARS-CoV-2, HIV-1, and hepatitis C virus; additional activities include anti-inflammatory, analgesic, and anti-Alzheimer's effects.

Conclusions:

• Benzimidazole-pyrimidine hybrids represent a promising class of compounds with diverse and potent therapeutic applications.
• SAR studies indicate that substituents on aromatic rings or linking the nuclei are crucial for optimizing activity.
• The development of approved drugs like Abemaciclib underscores the clinical relevance of this scaffold.